Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress

被引:264
作者
Imanishi, T [1 ]
Hano, T [1 ]
Nishio, I [1 ]
机构
[1] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418510, Japan
关键词
angiotensin II; endothelial progenitor cell; oxidative stress; senescence;
D O I
10.1097/00004872-200501000-00018
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives Recent studies have revealed an association between coronary risk factors and both the number and function of bone marrow-derived endothelial progenitor cell (EPC). We investigated the effect of angiotensin II (Ang II) on EPC senescence, leading to the impairment of proliferative activity. Methods and results EPCs were isolated from peripheral blood and characterized. Both reverse transcription (RT)-polymerase chain reaction (PCR) and Western blotting were used to assess gp91 phox expression. Immunofluorescence of nitrotyrosine provided evidence of peroxynitrite formation. Our data indicate that Ang II increased the expression of gp91 phox mRNA in a dose-dependent manner, which was attenuated by Ang II type 1 (AT,) receptor antagonist valsartan. Similarly, Western blotting revealed that Ang II stimulated an increase in gp91 phox, whereas pre-treatment with Valsartan reduced the Ang II-induced expression of gp91 phox protein. Valsartan as well as superoxide dismutase (SOD) also inhibited Ang II-induced peroxynitrite formation. The exposure of cultured EPC to Ang II (100 nmol/l) significantly accelerated the rate of senescence compared to a control during 14 days in culture as determined by acidic beta-galactosidase staining. Ang II-induced EPC senescence was significantly inhibited by pre-treatment of either valsartan or SOD (P < 0.01). Because cellular senescence is critically influenced by telomerase, which elongates telomeres, we measured telomerase activity by using PCR-enzyme-linked immunosorbent-based assay. Ang II significantly diminished telomerase activity, although the effect was significantly reduced by pretreatment with either valsartan or SOD (P < 0.01). We examined whether Ang II-induced EPC senescence translates into an impairment of EPC proliferation. MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenol)-2- (4-sulfophenyl)-2H-tetrazolium] assay disclosed an inhibitory effect of Ang II on EPC proliferation. Conclusions Ang II increases gp91 phox expression in EPC, which may contribute to oxidative stress, as evidenced by peroxynitrite formation. Ang II accelerates the onset of EPC senescence via increased oxidative stress, which may be related to telomerase inactivation. In addition, Ang II-induced EPC senescence leads to the impairment of proliferative activity. (C) 2005 Lippincott Williams Wilkins.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 33 条
  • [1] Reactive oxygen species as mediators of signal transduction in cardiovascular disease
    Abe, J
    Berk, BC
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 1998, 8 (02) : 59 - 64
  • [2] Isolation of putative progenitor endothelial cells for angiogenesis
    Asahara, T
    Murohara, T
    Sullivan, A
    Silver, M
    vanderZee, R
    Li, T
    Witzenbichler, B
    Schatteman, G
    Isner, JM
    [J]. SCIENCE, 1997, 275 (5302) : 964 - 967
  • [3] Extension of life-span by introduction of telomerase into normal human cells
    Bodnar, AG
    Ouellette, M
    Frolkis, M
    Holt, SE
    Chiu, CP
    Morin, GB
    Harley, CB
    Shay, JW
    Lichtsteiner, S
    Wright, WE
    [J]. SCIENCE, 1998, 279 (5349) : 349 - 352
  • [4] Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism
    Breitschopf, K
    Zeiher, AM
    Dimmeler, S
    [J]. FEBS LETTERS, 2001, 493 (01) : 21 - 25
  • [5] IDENTIFICATION OF ANGIOTENSIN-II RECEPTOR SUBTYPES
    CHIU, AT
    HERBLIN, WF
    MCCALL, DE
    ARDECKY, RJ
    CARINI, DJ
    DUNCIA, JV
    PEASE, LJ
    WONG, PC
    WEXLER, RR
    JOHNSON, AL
    TIMMERMANS, PBMWM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (01) : 196 - 203
  • [6] Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization
    Counter, CM
    Hahn, WC
    Wei, WY
    Caddle, SD
    Beijersbergen, RL
    Lansdorp, PM
    Sedivy, JM
    Weinberg, RA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) : 14723 - 14728
  • [7] Crow JP, 1996, ADV EXP MED BIOL, V387, P147
  • [8] A BIOMARKER THAT IDENTIFIES SENESCENT HUMAN-CELLS IN CULTURE AND IN AGING SKIN IN-VIVO
    DIMRI, GP
    LEE, XH
    BASILE, G
    ACOSTA, M
    SCOTT, C
    ROSKELLEY, C
    MEDRANO, EE
    LINSKENS, M
    RUBELJ, I
    PEREIRASMITH, O
    PEACOCKE, M
    CAMPISI, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) : 9363 - 9367
  • [9] MOLECULAR MECHANISMS OF VASCULAR RENIN-ANGIOTENSIN SYSTEM IN MYOINTIMAL HYPERPLASIA
    DZAU, VJ
    GIBBONS, GH
    PRATT, RE
    [J]. HYPERTENSION, 1991, 18 (04) : 100 - 105
  • [10] p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats
    Fukui, T
    Ishizaka, N
    Rajagopalan, S
    Lauren, JB
    Capers, Q
    Taylor, WR
    Harrison, DG
    deLeon, H
    Wilcox, JN
    Griendling, KK
    [J]. CIRCULATION RESEARCH, 1997, 80 (01) : 45 - 51